Question 1

What is the catalog number for PE/Cyanine7 anti-human TIGIT (VSTM3)?

Accepted Answer

The catalog number for PE/Cyanine7 anti-human TIGIT (VSTM3) is GT15379.

Question 2

What sizes are available for PE/Cyanine7 anti-human TIGIT (VSTM3)?

Accepted Answer

PE/Cyanine7 anti-human TIGIT (VSTM3) is available in the following size(s): 100 Tests.

Question 3

Is PE/Cyanine7 anti-human TIGIT (VSTM3) in stock?

Accepted Answer

PE/Cyanine7 anti-human TIGIT (VSTM3) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

PE/Cyanine7 anti-human TIGIT (VSTM3)

Product Specifications

Reactivity

Isotype

Clone

Conjugation

Applications

Specificity

Frequently Asked Questions

Explore Other Products

DOG-1 / TMEM16A (Gastrointestinal Stromal Tumor Marker) (rDG1/447), CF488A conjugate, 0.1mg/mL

Calretinin / Calbindin 2 (Mesothelioma Marker) (CALB2/2603), CF568 conjugate, 0.1mg/mL

Fascin-1 (FSCN1/416), CF488A conjugate, 0.1mg/mL

Cytokeratin, pan (Epithelial Marker) (KRTH/1576R + KRTL/1577R), CF488A conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), CF740 conjugate, 0.1mg/mL

Bcl-2 (Apoptosis & Follicular Lymphoma Marker) (BCL2/2210R), CF647 conjugate, 0.1mg/mL